Showing 6191-6200 of 7864 results for "".
- FDA Approves Higher Dilution in New Sculptra Labelhttps://practicaldermatology.com/news/fda-approves-higher-dilution-in-new-sculptra-label/2461007/A new FDA-approved label for Sculptra® (injectable poly-L-lactic acid (PLLA)) from Galderma includes higher dilution, the addition of immediate use reconstitution, new injection techniques, and the optional addition of lidocaine. Sculptra is the first and only FDA-approved PLLA facial in
- Cosmetic Surgery Forum Kicks Off in Nashvillehttps://practicaldermatology.com/news/cosmetic-surgery-forum-kicks-off-in-nashville/2461001/The no-nonsense presentations and candid audience contributions are center stage in Nashville as Cosmetic Surgery Forum kicks off with a live meeting after a hiatus last year, due to COVID-19 concerns. “We are ready to educate, inform, and have great discussions about topics that
- The Proactiv Company Rebrands to Alchemee, Expands Skincare Offeringshttps://practicaldermatology.com/news/the-proactiv-company-rebrands-to-alchemee-expands-skincare-offerings/2460998/The Proactiv Company is rebranding and repositioning under the new name Alchemee. Alchemee will cater to a multitude of skin concerns, and focus not only on consumers' needs, but on meeting them where they are along their journey through both innovation and an omni-channe
- Alastin to be Acquired by Galdermahttps://practicaldermatology.com/news/alastin-to-be-acquired-by-galderma/2460997/Galderma is set to acquire Alastin Skincare®, Inc. The world’s largest independent dermatology company has signed a definitive agreement to acquire the specialty aesthetics company dedicated to developing innovative and clinically-tested physician-dispensed skincare products. Financial
- Novel Lyme Vaccine Shows Promise in Early Researchhttps://practicaldermatology.com/news/novel-lyme-vaccine-shows-promise-in-early-research/2460994/Yale University researchers have developed a novel vaccine that in guinea pigs offers protection against infection by the bacterium that causes Lyme disease and may also combat other tick-borne diseases, they report in the journal Science Translational Medicine. Instead of trig
- South Florida Women's Shelter Dedicates Shade Structureshttps://practicaldermatology.com/news/south-florida-womens-shelter-dedicates-shades-structures/2460992/Aid to Victims of Domestic Abuse, Inc. (AVDA) in Delray Beach, FL dedicated its new shade structure at the Casa Vegso Residential Campus last month. The structure was funded by an American Academy of Dermatology Shade Structure Grant and SafeSun, Inc., a nonprofit organization dedicated to the pr
- Derms Give Back: Caring for Veteranshttps://practicaldermatology.com/news/derms-give-back-caring-for-veterans/2460989/Caring for veterans inspires dermatologists like Joshua E. Lane, MD every single day. Dr. Lane practices in Columbus, GA, near Fort Benning, a large military base, and many of his patients are veterans. He was so moved by their service and selflessness that he joined the
- National Rosacea Society Awards 2021 Research Grantshttps://practicaldermatology.com/news/national-rosacea-society-awards-2021-research-grants/2460988/The National Rosacea Society has awarded funding for two new studies in addition to continuing support for two ongoing studies as part of its
- With New Agreement, DermTech Melanoma Test Available Through DermatologistOnCallhttps://practicaldermatology.com/news/with-new-agreement-dermtech-melanoma-test-available-through-dermatologistoncall/2460987/The DermTech Melanoma Test is now available through DermatologistOnCall’s telemedicine platform. The DermTech Melanoma Test is a non-invasive test used to painlessly collect cellular material from the surface of a patient’s mole via t
- PsA Treatment Snapshot: Study Highlights Trends in PsA Treatment Since 2018https://practicaldermatology.com/news/psa-treatment-snapshot-study-highlights-trends-in-psa-treatment-since-2018/2460985/There’s been a significant increase in anti-IL17 and anti-phosphodiesterase-4 (anti-PDE4) medications being used as initial treatment for psoriatic arthritis (PsA) since 2018, which may reflect their inclusion as potential initial therapy in the American College of Rheumatology/National Pso